CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Paresthesia mapping lead evaluation first +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02986074
NCT02986074N/ACompleted
CompareCT.gov

CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies

Abbott Medical Devices·interventional·Posted Dec 8, 2016·Updated Jun 22, 2026

In Brief

A clinical study evaluating Paresthesia mapping lead evaluation first and Anatomical midline lead evaluation first for Chronic Pain. Completed, enrolled 60 participants across 2 sites.

Detailed Summary

The study will compare therapeutic efficacy of a novel spinal cord stimulation leads implant based on anatomical landmarks with standard surgical implantation technique.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesUnited Kingdom
CollaboratorsGuy's and St Thomas' NHS Foundation Trust, Seacroft Hospital

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 8, 2016
Enrollment StartNov 1, 2016
Primary CompletionAug 19, 2019
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 9.6 years ago

Interventions

Paresthesia mapping lead evaluation firstdevice

Subjects will evaluate the clinical efficacy of stimulation delivered using the lead implanted using paresthesia mapping in the first part of the SCS trial and using the lead implanted using anatomical midline placement in the second part of the SCS trial

Anatomical midline lead evaluation firstdevice

Subjects will evaluate the clinical efficacy of stimulation delivered using the lead implanted using anatomical midline in the first part of the SCS trial and using the lead implanted using paresthesia mapping placement in the second part of the SCS trial